Article Details

Zoetis Receives European Commission Marketing Authorization for Solensia® (frunevetmab), a ...

Retrieved on: 2021-02-22 07:52:30

Tags for this article:

Click the tags to see associated articles and topics

Zoetis Receives European Commission Marketing Authorization for Solensia® (frunevetmab), a .... View article details on hiswai:

Excerpt

“At Zoetis, our monoclonal antibody research continues to advance the care of animals, and our platform allows us to explore new therapeutic areas ...

Article found on: www.digitaljournal.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo